Company · Toronto, Ontario, Canada
AA Pharma Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 210
- 200 authorized now
- Natural health products
- 1
- 1 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 244
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| AA-AMILZIDE | 00784400 | Marketed | |
| AA-ATENIDONE | 02248763 | Marketed | |
| AA-ATENIDONE | 02248764 | Marketed | |
| AA-CLOZAPINE | 02248034 | Marketed | |
| AA-CLOZAPINE | 02248035 | Marketed | |
| AA-CLOZAPINE | 02458748 | Marketed | |
| AA-CLOZAPINE | 02458756 | Marketed | |
| AA-DILTIAZ | 00771376 | Marketed | |
| AA-DILTIAZ | 00771384 | Marketed | |
| AA-FENO-MICRO | 02239864 | Marketed | |
| AA-FENO-MICRO | 02243180 | Marketed | |
| AA-FENO-SUPER | 02246859 | Marketed | |
| AA-FENO-SUPER | 02246860 | Marketed | |
| AA-IPRAVENT | 02126222 | Marketed | |
| AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN | 02470780 | Marketed | |
| AA-LEVOCARB CR | 02245211 | Marketed | |
| AA-LEVOCARB CR | 02272873 | Marketed | |
| AA-MEDROXY | 02244726 | Marketed | |
| AA-MEDROXY | 02244727 | Marketed | |
| AA-MEDROXY | 02267640 | Marketed | |
| AA-MEDROXY | 02277298 | Marketed | |
| AA-METHYLPHENIDATE SR | 02266687 | Marketed | |
| AA-METOPROLOL SR | 02285169 | Marketed | |
| AA-RISEDRONATE DR | 02493268 | Marketed | |
| AA-SUCRALFATE | 02125250 | Marketed | |
| AA-THEO LA | 00692700 | Marketed | |
| AA-THEO LA | 00692697 | Marketed | |
| AA-THEO LA | 00692689 | Marketed | |
| AA-VERAP | 00782491 | Marketed | |
| AA-VERAP | 00782483 | Marketed | |
| ACETAZOLAMIDE | 00545015 | Marketed | |
| AVENTYL | 00015229 | Marketed | |
| AVENTYL | 00015237 | Marketed | |
| BENAZEPRIL | 02273918 | Marketed | |
| BENAZEPRIL | 02290332 | Marketed | |
| BENAZEPRIL | 02290340 | Marketed | |
| BRIMONIDINE P | 02301334 | Marketed | |
| BROMOCRIPTINE | 02087324 | Marketed | |
| BROMOCRIPTINE | 02230454 | Marketed | |
| BUTORPHANOL NASAL SPRAY | 02242504 | Marketed | |
| CHLORDIAZEPOXIDE | 00522996 | Marketed | |
| CIMETIDINE | 00584215 | Marketed | |
| CIMETIDINE | 00487872 | Marketed | |
| CLORAZEPATE | 00860697 | Marketed | |
| CLORAZEPATE | 00860689 | Marketed | |
| CLORAZEPATE | 00860700 | Marketed | |
| CYPROTERONE | 02245898 | Marketed | |
| DESIPRAMINE | 02216248 | Marketed | |
| DESIPRAMINE | 02216256 | Marketed | |
| DESIPRAMINE | 02216280 | Marketed | |
| DESIPRAMINE | 02216272 | Marketed | |
| DESIPRAMINE | 02216264 | Marketed | |
| DESMOPRESSIN SPRAY | 02242465 | Marketed | |
| DEXTROAMPHETAMINE | 02443236 | Marketed | |
| DIAZEPAM | 00362158 | Marketed | |
| DIAZEPAM | 00405329 | Marketed | |
| DIAZEPAM | 00405337 | Marketed | |
| ENALAPRIL MALEATE/HCTZ | 02352923 | Marketed | |
| ENALAPRIL MALEATE/HCTZ | 02352931 | Marketed | |
| FLUNARIZINE | 02246082 | Marketed | |
| FLUPHENAZINE | 00405345 | Marketed | |
| FLUPHENAZINE | 00405361 | Marketed | |
| FLUPHENAZINE | 00410632 | Marketed | |
| FLURAZEPAM | 00521698 | Marketed | |
| FLURAZEPAM | 00521701 | Marketed | |
| FLURBIPROFEN | 01912038 | Marketed | |
| FLURBIPROFEN | 01912046 | Marketed | |
| FLUTAMIDE | 02238560 | Marketed | |
| FOLIC ACID | 00426849 | Marketed | |
| HYDROXYZINE | 00646016 | Marketed | |
| HYDROXYZINE | 00646024 | Marketed | |
| HYDROXYZINE | 00646059 | Marketed | |
| IPRAVENT | 02246084 | Marketed | |
| ISDN | 00441686 | Marketed | |
| ISDN | 00441694 | Marketed | |
| KETOPROFEN SR | 02172577 | Marketed | |
| KETOPROFEN-E | 00842664 | Marketed | |
| KETOPROFEN-E | 00790435 | Marketed | |
| KETOROLAC | 02245821 | Marketed | |
| LITHMAX | 02266695 | Marketed | |
| LORAZEPAM SUBLINGUAL | 02410745 | Marketed | |
| LORAZEPAM SUBLINGUAL | 02410753 | Marketed | |
| LORAZEPAM SUBLINGUAL | 02410761 | Marketed | |
| LOVASTATIN | 02220172 | Marketed | |
| LOVASTATIN | 02220180 | Marketed | |
| MEFENAMIC | 02229452 | Marketed | |
| MEFLOQUINE | 02244366 | Marketed | |
| MEGESTROL | 02195925 | Marketed | |
| MEGESTROL | 02195917 | Marketed | |
| METHAZOLAMIDE | 02245882 | Marketed | |
| METHOPRAZINE | 02238403 | Marketed | |
| METHOPRAZINE | 02238404 | Marketed | |
| METHOPRAZINE | 02238405 | Marketed | |
| METHOPRAZINE | 02238406 | Marketed | |
| METHYLDOPA | 00360252 | Marketed | |
| METHYLDOPA | 00360260 | Marketed | |
| METHYLDOPA | 00426830 | Marketed | |
| MIDAMOR | 02249510 | Marketed | |
| MINOCYCLINE | 02084104 | Marketed | |
| MINOCYCLINE | 02084090 | Marketed | |
| MISOPROSTOL | 02244022 | Marketed | |
| MISOPROSTOL | 02244023 | Marketed | |
| MOCLOBEMIDE | 02232148 | Marketed | |
| MOCLOBEMIDE | 02232150 | Marketed | |
| MOCLOBEMIDE | 02240456 | Marketed | |
| MOGADON | 00511528 | Marketed | |
| MOGADON | 00511536 | Marketed | |
| NABUMETONE | 02238639 | Marketed | |
| NIFEDIPINE | 00755907 | Marketed | |
| NIFEDIPINE | 00725110 | Marketed | |
| NITROFURANTOIN | 00312738 | Marketed | |
| NITROFURANTOIN | 00319511 | Marketed | |
| NORFLOXACIN | 02229524 | Marketed | |
| PEN-VK | 00642215 | Marketed | |
| PERPHENAZINE | 00335096 | Marketed | |
| PERPHENAZINE | 00335118 | Marketed | |
| PERPHENAZINE | 00335126 | Marketed | |
| PERPHENAZINE | 00335134 | Marketed | |
| PHENYTOIN SODIUM | 02460912 | Marketed | |
| PIMOZIDE | 02245432 | Marketed | |
| PIMOZIDE | 02245433 | Marketed | |
| PINAVERIUM | 02469677 | Marketed | |
| PINAVERIUM | 02469685 | Marketed | |
| PRIMIDONE | 00396761 | Marketed | |
| PRIMIDONE | 00399310 | Marketed | |
| PROCHLORAZINE | 00886432 | Marketed | |
| PROCHLORAZINE | 00886440 | Marketed | |
| RESTORIL | 00604453 | Marketed | |
| RESTORIL | 00604461 | Marketed | |
| ROSIGLITAZONE | 02403366 | Marketed | |
| ROSIGLITAZONE | 02403374 | Marketed | |
| ROSIGLITAZONE | 02403382 | Marketed | |
| SELEGILINE | 02230641 | Marketed | |
| SINEQUAN | 00024325 | Marketed | |
| SINEQUAN | 00024333 | Marketed | |
| SINEQUAN | 00024341 | Marketed | |
| SINEQUAN | 00326925 | Marketed | |
| SINEQUAN | 00400750 | Marketed | |
| SULFATRIM | 00445274 | Marketed | |
| SULFATRIM DS | 00445282 | Marketed | |
| SULFATRIM PEDIATRIC | 00445266 | Marketed | |
| TETRACYCLINE | 00580929 | Marketed | |
| THEO ER | 02360101 | Marketed | |
| THEO ER | 02360128 | Marketed | |
| TIMOLOL | 00755842 | Marketed | |
| TIMOLOL | 00755850 | Marketed | |
| TIMOLOL | 00755869 | Marketed | |
| TORADOL | 02162660 | Marketed | |
| TRIAZOLAM | 00808571 | Marketed | |
| TRIHEXYPHENIDYL | 00545058 | Marketed | |
| TRIHEXYPHENIDYL | 00545074 | Marketed | |
| TRIMETHOPRIM TABLETS | 02243116 | Marketed | |
| TRIMETHOPRIM TABLETS | 02243117 | Marketed | |
| TRIMIPRAMINE | 00740799 | Marketed | |
| TRIMIPRAMINE | 00740802 | Marketed | |
| TRIMIPRAMINE | 00740810 | Marketed | |
| TRIMIPRAMINE | 00740829 | Marketed | |
| TRIMIPRAMINE | 02070987 | Marketed | |
| WINPRED | 00271373 | Marketed | |
| AA-ADEFOVIR | 02420333 | Dormant | |
| AA-FENO-SUPER | 02246861 | Approved | |
| AA-METOPROLOL SR | 02285177 | Dormant | |
| CHLORAX | 00618454 | Dormant | |
| CHLORDIAZEPOXIDE | 00522724 | Dormant | |
| CHLORDIAZEPOXIDE | 00522988 | Dormant | |
| CIMETIDINE | 00600059 | Dormant | |
| CIMETIDINE | 00600067 | Dormant | |
| CIMETIDINE | 00749494 | Dormant | |
| DIFLUNISAL | 02039494 | Dormant | |
| DIFLUNISAL | 02039486 | Dormant | |
| ELAVIL | 00335053 | Dormant | |
| ELAVIL | 00335061 | Dormant | |
| ELAVIL | 00335088 | Dormant | |
| ELAVIL | 00754129 | Dormant | |
| ERYTHRO-BASE | 00682020 | Dormant | |
| ERYTHRO-S | 00545678 | Dormant | |
| ETODOLAC | 02232317 | Dormant | |
| ETODOLAC | 02232318 | Dormant | |
| FENOFIBRATE | 02225980 | Dormant | |
| FLOCTAFENINE | 02244680 | Dormant | |
| FLOCTAFENINE | 02244681 | Dormant | |
| IPRAVENT | 02246083 | Dormant | |
| ISDN | 00670944 | Dormant | |
| KETOPROFEN | 00790427 | Dormant | |
| MINIPRESS | 00560979 | Dormant | |
| MINIPRESS | 00560952 | Dormant | |
| MINIPRESS | 00560960 | Dormant | |
| ORAP | 00313815 | Dormant | |
| ORAP | 00313823 | Dormant | |
| ORCIPRENALINE | 02236783 | Dormant | |
| PONSTAN | 00155225 | Dormant | |
| SULFINPYRAZONE | 00441767 | Dormant | |
| TENOXICAM | 02230661 | Dormant | |
| TICLOPIDINE | 02237701 | Dormant | |
| TOLBUTAMIDE | 00312762 | Dormant | |
| TRIFLUOPERAZINE | 00312746 | Dormant | |
| TRIFLUOPERAZINE | 00312754 | Dormant | |
| TRIFLUOPERAZINE | 00326836 | Dormant | |
| TRIFLUOPERAZINE | 00345539 | Dormant | |
| TRIFLUOPERAZINE | 00595942 | Dormant | |
| ERYTHRO-EC | 00726672 | Cancelled Post Market | |
| ERYTHRO-EC | 01925938 | Cancelled Post Market | |
| ERYTHRO-ES | 00637416 | Cancelled Post Market | |
| ERYTHRO-S | 00688568 | Cancelled Post Market | |
| NITRAZADON | 02229654 | Cancelled Post Market | |
| NITRAZADON | 02229655 | Cancelled Post Market | |
| OFLOXACIN TABLETS | 02231529 | Cancelled Post Market | |
| OFLOXACIN TABLETS | 02231531 | Cancelled Post Market | |
| OFLOXACIN TABLETS | 02231532 | Cancelled Post Market | |
| TRIAZOLAM | 00808563 | Cancelled Post Market |
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| APO-FERROUS GLUCONATE | 00545031 | Active |
Notices of Compliance
Newest first.
- AA-SUCRALFATESeptember 24, 2026 · NOC 38360 · New Drug Submission (NDS)
- AA-MEDROXYJuly 24, 2026 · NOC 37982 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SULFATRIM; SULFATRIM DS; SULFATRIM PEDIATRICJuly 23, 2026 · NOC 37973 · Supplement to a New Drug Submission (SNDS)
- AA-MEDROXYMay 29, 2026 · NOC 37644 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ORAPMay 13, 2026 · NOC 37533 · Supplement to a New Drug Submission (SNDS)
- PONSTANApril 2, 2026 · NOC 37262 · Supplement to a New Drug Submission (SNDS)
- TRIAZOLAMJanuary 5, 2026 · NOC 36681 · Supplement to a New Drug Submission (SNDS)
- AA-METHYLPHENIDATE SRNovember 7, 2025 · NOC 36347 · Abbreviated New Drug Submission (ANDS)
- AA-DILTIAZNovember 7, 2025 · NOC 36348 · Supplement to a New Drug Submission (SNDS)
- AA-VERAPOctober 14, 2025 · NOC 36298 · New Drug Submission (NDS)
- MIDAMORAugust 28, 2025 · NOC 35921 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LOVASTATINJuly 29, 2025 · NOC 35763 · Supplement to a New Drug Submission (SNDS)
- BENAZEPRILJune 24, 2025 · NOC 35564 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MIDAMORJune 10, 2025 · NOC 35489 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ISDNMay 30, 2025 · NOC 35446 · Supplement to a New Drug Submission (SNDS)
- TIMOLOLMay 29, 2025 · NOC 35445 · Supplement to a New Drug Submission (SNDS)
- NORFLOXACINMay 29, 2025 · NOC 35450 · Supplement to a New Drug Submission (SNDS)
- MEFLOQUINEMay 1, 2025 · NOC 35285 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LITHMAXApril 1, 2025 · NOC 35107 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TORADOLMarch 28, 2025 · NOC 35086 · Supplement to a New Drug Submission (SNDS)
- AA-MEDROXYMarch 12, 2025 · NOC 34997 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DEXTROAMPHETAMINEJanuary 14, 2025 · NOC 34682 · Supplement to a New Drug Submission (SNDS)
- AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCINOctober 18, 2024 · NOC 34281 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MEFENAMICSeptember 3, 2024 · NOC 33917 · New Drug Submission (NDS)
- DESMOPRESSIN SPRAYSeptember 3, 2024 · NOC 33924 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TORADOLAugust 9, 2024 · NOC 33784 · Supplement to a New Drug Submission (SNDS)
- AA-ATENIDONEAugust 1, 2024 · NOC 33750 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AA-MEDROXYJune 20, 2024 · NOC 33474 · Abbreviated New Drug Submission (ANDS)
- PONSTANApril 16, 2024 · NOC 33066 · Supplement to a New Drug Submission (SNDS)
- FLOCTAFENINEApril 16, 2024 · NOC 33067 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MINIPRESSMarch 15, 2024 · NOC 32900 · Supplement to a New Drug Submission (SNDS)
- SULFATRIM; SULFATRIM DS TABLETS; SULFATRIM PEDIATRICJanuary 14, 2024 · NOC 34689 · Supplement to a New Drug Submission (SNDS)
- MEFLOQUINEDecember 18, 2023 · NOC 32367 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NIFEDIPINEDecember 5, 2023 · NOC 32285 · Supplement to a New Drug Submission (SNDS)
- AA-DILTIAZSeptember 22, 2023 · NOC 31703 · Supplement to a New Drug Submission (SNDS)
- AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCINSeptember 15, 2023 · NOC 31632 · Supplement to an Abbreviated New Drug Submission (SANDS)
- BRIMONIDINE PSeptember 13, 2023 · NOC 31613 · Supplement to an Abbreviated New Drug Submission (SANDS)
- KETOROLACSeptember 13, 2023 · NOC 31614 · Supplement to a New Drug Submission (SNDS)
- AA-RISEDRONATE DRSeptember 8, 2023 · NOC 31582 · Abbreviated New Drug Submission (ANDS)
- AA-IPRAVENTSeptember 5, 2023 · NOC 31544 · New Drug Submission (NDS)
- SULFATRIM; SULFATRIM DS; SULFATRIM PEDIATRICAugust 16, 2023 · NOC 31435 · Supplement to a New Drug Submission (SNDS)
- AVENTYLJuly 26, 2023 · NOC 31310 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MOCLOBEMIDEJuly 5, 2023 · NOC 31126 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LORAZEPAM SUBLINGUALJune 30, 2023 · NOC 31111 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AA-LEVOCARB CRJune 12, 2023 · NOC 30972 · Supplement to a New Drug Submission (SNDS)
- ENALAPRIL MALEATE /HCTZMay 15, 2023 · NOC 30764 · Supplement to a New Drug Submission (SNDS)
- ELAVILMay 9, 2023 · NOC 30693 · Supplement to a New Drug Submission (SNDS)
- TORADOLApril 14, 2023 · NOC 30517 · Supplement to a New Drug Submission (SNDS)
- AA-CLOZAPINEApril 4, 2023 · NOC 30458 · Supplement to a New Drug Submission (SNDS)
- CYPROTERONEMarch 31, 2023 · NOC 30440 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NABUMETONEMarch 24, 2023 · NOC 30390 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AA-AMILZIDEMarch 17, 2023 · NOC 30340 · Supplement to a New Drug Submission (SNDS)
- BUTORPHANOL NASAL SPRAYJanuary 26, 2023 · NOC 29996 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AA-ATENIDONEJanuary 18, 2023 · NOC 29922 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PHENYTOIN SODIUMDecember 30, 2022 · NOC 29804 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DESIPRAMINEDecember 16, 2022 · NOC 29722 · New Drug Submission (NDS)
- ORCIPRENALINEOctober 14, 2022 · NOC 29204 · Abbreviated New Drug Submission (ANDS)
- NABUMETONEOctober 14, 2022 · NOC 29205 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AA-METOPROLOL SROctober 13, 2022 · NOC 29189 · New Drug Submission (NDS)
- TIZANIDINEOctober 4, 2022 · NOC 29117 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCINOctober 4, 2022 · NOC 29152 · Abbreviated New Drug Submission (ANDS)
- DIFLUNISALSeptember 26, 2022 · NOC 29081 · Supplement to a New Drug Submission (SNDS)
- TENOXICAMSeptember 1, 2022 · NOC 28873 · New Drug Submission (NDS)
- TICLOPIDINESeptember 1, 2022 · NOC 28887 · New Drug Submission (NDS)
- AVENTYLAugust 18, 2022 · NOC 28793 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ELAVILJune 2, 2022 · NOC 28312 · Supplement to a New Drug Submission (SNDS)
- KETOPROFEN; KETOPROFEN SR; KETOPROFEN-EMay 10, 2022 · NOC 28124 · Supplement to a New Drug Submission (SNDS)
- BUTORPHANOL NASAL SPRAYMay 6, 2022 · NOC 28097 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LORAZEPAM SUBLINGUALMay 2, 2022 · NOC 28061 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TORADOLApril 6, 2022 · NOC 27930 · Supplement to a New Drug Submission (SNDS)
- DESMOPRESSIN SPRAYMarch 30, 2022 · NOC 27850 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AA-FENO-MICROMarch 23, 2022 · NOC 27808 · Supplement to a New Drug Submission (SNDS)
- FLURBIPROFENMarch 19, 2022 · NOC 27846 · Supplement to a New Drug Submission (SNDS)
- FLUTAMIDEMarch 1, 2022 · NOC 27683 · Supplement to an Abbreviated New Drug Submission (SANDS)
- FLUNARIZINEFebruary 17, 2022 · NOC 27618 · Supplement to an Abbreviated New Drug Submission (SANDS)
- BROMOCRIPTINEFebruary 16, 2022 · NOC 27612 · Supplement to a New Drug Submission (SNDS)
- CIMETIDINEFebruary 11, 2022 · NOC 27574 · Supplement to a New Drug Submission (SNDS)
- PENTOXIFYLLINE SRJanuary 28, 2022 · NOC 27495 · Supplement to a New Drug Submission (SNDS)
- DIAZEPAMJanuary 24, 2022 · NOC 27453 · Supplement to a New Drug Submission (SNDS)
- AA-THEO LAJanuary 14, 2022 · NOC 27397 · Supplement to a New Drug Submission (SNDS)
- AVENTYLJanuary 10, 2022 · NOC 27362 · Abbreviated New Drug Submission (ANDS)
- TRIAZOLAMDecember 17, 2021 · NOC 27259 · Supplement to a New Drug Submission (SNDS)
- CLORAZEPATEDecember 17, 2021 · NOC 27260 · Supplement to a New Drug Submission (SNDS)
- CHLORAXDecember 16, 2021 · NOC 27254 · Supplement to a New Drug Submission (SNDS)
- SULFATRIM; SULFATRIM DS; SULFATRIM PEDIATRICDecember 15, 2021 · NOC 27249 · Supplement to a New Drug Submission (SNDS)
- ETODOLACDecember 10, 2021 · NOC 27216 · Abbreviated New Drug Submission (ANDS)
- RESTORILNovember 16, 2021 · NOC 27041 · Supplement to a New Drug Submission (SNDS)
- TIZANIDINENovember 12, 2021 · NOC 27021 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NABUMETONENovember 8, 2021 · NOC 26986 · Abbreviated New Drug Submission (ANDS)
- TIZANIDINEOctober 28, 2021 · NOC 26923 · Supplement to an Abbreviated New Drug Submission (SANDS)
- FLURAZEPAMOctober 14, 2021 · NOC 26837 · Supplement to a New Drug Submission (SNDS)
- THEO ERSeptember 29, 2021 · NOC 26754 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MEGESTROLSeptember 23, 2021 · NOC 26710 · New Drug Submission (NDS)
- ZYLOPRIMSeptember 3, 2021 · NOC 26599 · Supplement to a New Drug Submission (SNDS)
- AA-FENO-SUPERAugust 17, 2021 · NOC 26454 · Abbreviated New Drug Submission (ANDS)
- MOGADONAugust 12, 2021 · NOC 26444 · Supplement to a New Drug Submission (SNDS)
- TEMAZEPAMAugust 11, 2021 · NOC 26421 · New Drug Submission (NDS)
- AA-TELMISARTAN-AMLODIPINEApril 15, 2021 · NOC 25676 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SULFATRIM; SULFATRIM DS; SULFATRIM PEDIATRICApril 8, 2021 · NOC 25617 · Supplement to a New Drug Submission (SNDS)
- AA-ADEFOVIRApril 6, 2021 · NOC 25605 · Abbreviated New Drug Submission (ANDS)
The latest 100 of 244.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- AA-FENO-SUPER: Product QualityMay 5, 2022 · Drugs · Product quality · Type III